Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Celltrion (068270) – Marketing Authorization Granted by South Korean MFDS for Eydenzelt (CT-P42, Eylea Biosimilar) / 2024-05-30 Disclosures
  • [Disclosure] Celltrion (068270) – Treasury Share Acquisition Decision / 2024-04-17 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Investor Relations (IR) Holding / 2024-05-03 Disclosures
  • [Disclosure] Celltrion (068270) – Approval of IND Amendment for CT-P51 (Keytruda Biosimilar) Korea Phase 3 Clinical Trial / 2026-04-24 Disclosures
  • [Disclosure] HPSP (403870) – Resolution on Calling of General Meeting of Shareholders / 2026-03-12 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – iM Securities | Downcycle Earnings Defense · Range-Bound Share Price · Hold Rating / 2025-02-28 RESEARCH
  • [Disclosure] SK Hynix (000660 / SKHY) – Matters Related to Sustainability Report, etc. / 2026-06-25 Semiconductors
  • [Research] Samsung Electro-Mechanics (009150) – Daishin Securities | High-Value MLCC & FC-BGA · AI Server Expansion · High-Growth Earnings / 2024-08-01 RESEARCH

[Disclosure] Daeduck Electronics (353200) – Investor Relations (IR) Holding (Information Disclosure) / 2025-04-17

Posted on April 17, 2025August 4, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Daeduck Electronics is hosting an Investor Relations (IR) event for domestic institutional investors to present its Q1 2025 financial results and business outlook.

📊 [Key Disclosure Details & Financial Figures]

  • Date & Time: May 7, 2025 – May 9, 2025 (Starting at 09:00 KST)
  • Location: Conference rooms for institutional investors in Seoul, South Korea
  • Target Audience: Domestic institutional investors
  • Purpose: Presentation of Q1 2025 earnings results and future performance outlook
  • Format: Conference calls, 1-on-1 meetings, or group meetings
  • Sponsoring Brokerage: iM Securities
  • Key Agenda: Q1 2025 financial performance explanation and Q&A on key investor inquiries
  • IR Material Release Date & Location: April 29, 2025 (Company Website → IR → Earnings Results)
  • Other Details: The Non-Deal Roadshow (NDR) period runs for 3 days from May 7 to May 9, 2025

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of IR Presentation Materials and Confirmed Financial Results

The company will present its Q1 2025 financial performance and business outlook at this Investor Relations event. Reviewing the IR presentation material disclosed prior to the event alongside the upcoming quarterly report is essential to understanding the company’s financial results and segment-specific operational performance. Relevant information can be verified in the IR presentation uploaded to the company’s website on April 29, 2025, and in the subsequent quarterly report filed on DART.

📢 Disclaimer and Source Information

Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific security. All investment decisions and financial responsibilities rest entirely with the individual investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Semiconductors, Disclosures

Post navigation

Previous Post: [Disclosure] Hyundai Motor (005380) – Investor Relations (IR) Holding (Notice) / 2025-04-17
Next Post: [Disclosure] Daeduck Electronics (353200) – Advance Notice of Earnings Release (Information Disclosure) / 2025-04-17

Related Posts

  • [Disclosure] Celltrion (068270) – Approval for Amendment of Phase 3 Clinical Trial Plan for CT-P55 (Cosentyx Biosimilar) in Europe (Part 1 & 2) / 2026-02-10 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Result of Action Such as Prosecution Referral for Violation of Accounting Standards / 2025-07-17 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2025-12-19 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or News Reports (Unconfirmed) / 2025-10-17 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Provisional Consolidated Financial Results (Fair Disclosure) / 2025-10-14 Semiconductors
  • [Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P13 SC (Zymfentra) in the U.S. (Rheumatoid Arthritis) / 2024-06-19 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2025-07-29 Disclosures
  • [Research] SK hynix (000660 / SKHY) – SK Securities | AI Memory · NAND Tiering · Earnings Re-rating / 2026-02-24 RESEARCH
  • [Disclosure] Hanwha Ocean (042660) – Investor Relations (IR) Holding Notice / 2025-10-13 Disclosures
  • [Disclosure] Hana Micron (067310) – (Correction) Setting of Closure Period of Shareholders’ Register or Record Date / 2024-12-16 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Ex-Dividend Reference Price Notice for Interim (Quarterly) Dividend / 2025-08-27 Disclosures
  • [Disclosure] KEPCO (015760 / KEP) – Other Corporate Matters (Voluntary Disclosure) / 2026-03-30 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Provisional Operating Results (Consolidated) / 2024-04-30 Disclosures
  • [Disclosure] Samsung Electro-Mechanics (009150) – Consolidated Earnings Announcement (Provisional) / 2026-01-23 Semiconductors

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme